A Phase I Study of Oral Uracil-Tegafur Prior to Weekly Intravenous Gemcitabine in Patients with Advanced Pancreatic Cancer

Publisher： Karger

E-ISSN： 1421-9794|52|2|98-102

ISSN： 0009-3157

Source： Chemotherapy, Vol.52, Iss.2, 2006-04, pp. : 98-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I Trial Using Weekly Administration of Gemcitabine and Docetaxel in Patients with Advanced Pancreatic Carcinoma

By  

Chemotherapy, Vol. 50, Iss. 6, 2004-12 ,pp. : 289-296

Karger

Access to resources Recommend Favorite

Fixed Dose Rate Infusion of Gemcitabine with Oral Doxifluridine and Leucovorin for Advanced Unresectable Pancreatic Cancer: A Phase II Study

By  

Chemotherapy, Vol. 54, Iss. 1, 2007-12 ,pp. : 54-62

Karger

Access to resources Recommend Favorite

Phase I Trial of Gemcitabine Combined with Capecitabine and Erlotinib in Advanced Pancreatic Cancer: A Clinical and Pharmacological Study

By  

Chemotherapy, Vol. 58, Iss. 5, 2012-12 ,pp. : 371-380

Karger

Access to resources Recommend Favorite

A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 58, Iss. 1, 2012-02 ,pp. : 78-83

Karger

Access to resources Recommend Favorite

Phase I Study of Weekly Irinotecan Combined with Weekly Cisplatin in Patients with Advanced Solid Tumors

By  

Chemotherapy, Vol. 48, Iss. 4, 2002-09 ,pp. : 205-210

Karger

Access to resources Recommend Favorite